Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and paricalcitol

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with paricalcitol in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(paricalcitol)		Trials
(paricalcitol)		Recent Studies (post-2010) (paricalcitol)
9,156187552516100288

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alevizopoulou, F; Demopoulos, CA; Iatrou, C; Tsoupras, AB; Verouti, SN1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and paricalcitol

ArticleYear
Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.
    The International journal of artificial organs, 2013, Volume: 36, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Animals; Blood Platelets; Cytokines; Diacylglycerol Cholinephosphotransferase; Dose-Response Relationship, Drug; Ergocalciferols; Humans; Inflammation Mediators; Leukocytes; Pilot Projects; Platelet Activating Factor; Platelet Aggregation; Rabbits; Renal Dialysis; Renal Insufficiency, Chronic; Thrombin; Time Factors

2013